Board of Directors

Gérard Hascoët,

Chairman of the Board of CorWave. As a “Serial entrepreneur” of medical devices, he founded companies such as Technomed International, IMMI and Sometec, all of which were acquired or floated on the stock market. Gérard is also President of MD Start and EOS Imaging, is on the Board of Directors of Pixium Vision, Precardia, Ablacare and Limflow, and is Venture Partner at Sofinnova.


Louis de Lillers,
CEO of CorWave

CEO of CorWave since 2015, Louis has over 10 years of experience in the fields of LVAD and venture capital. He previously co-founded PlugMed, a medtech company and worked at Clipperton Finance and Sofinnova Partners. Louis graduated from EDHEC Business School and holds a university degree in artificial heart and circulatory support from Pitié-Salpêtrière.


Philippe Boucheron,
representing Bpifrance Participations

Investment Director at BPI France Participations, Philippe graduated from École Polytechnique Montréal and holds a MBA from INSEAD. He has over 20 years of investment experience in life sciences.


Emmanuelle Coutanceau,
representing Novo Holdings

Partner at Novo Holdings, Emmanuelle has more than 10 years of venture capital experience. Before joining Novo Holdings, she was a partner at Auriga Partners, specializing in life sciences, and worked at Omnes Capital. She serves on the boards of Draupnir, Minervax, IO Biotech, Heparegenix and Inthera.


Raúl Martín-Ruiz, representing Ysios Capital

Partner at Ysios Capital, Raúl graduated with a PhD degree in neurosciences. He has more than 25 years of experience in life sciences including academia, pharma and venture capital. He sits on the board of Anaconda Biomed, and previously of STAT Diagnostica (acquired by Qiagen), Prexton Therapeutics (acquired by Lundbeck) and MedLumics.


Jim Schuermann,
independent board member

Jim has over 20 years of experience in medical devices, including more than a decade in LVADs. He was instrumental in transforming HeartWare, an LVAD start-up valued around $100M when he joined, into a $Bn Nasdaq-listed company. As Senior VP Sales & Marketing he led a rapid commercial scale-up from 0 to about $300M in annual sales. After HeartWare’s $1.1Bn acquisition by Medtronic in 2016, he became Vice President and General Manager of Medtronic’s Mechanical Circulatory Support Division. Prior to joining HeartWare, Jim spent nearly a decade at Boston Scientific. In 2018, he joined Avedro, an ophthalmic pharmaceutical and medical device company acquired by Glaukos in late 2019 for about $450M, as Chief Business Officer.


Michel Darnaud,
independent board member

Independent Director, former President of the Cardiac Surgery Business Unit at Livanova. He has over 30 years of experience in the medical technology field, including two decades in management positions. Between 2008 and 2016, he led LivaNova’s cardiovascular business, with overall responsibility from R&D to sales. In addition, he was president of the European Medical Device Industry Association (Eucomed) in 2004-2005. He is also Chairman of the Board of Stentys.


Marie Meynadier,
independent board member

A graduate from Sup Telecom with a doctorate from Ecole Normale Supérieure, she has more than 25 years of experience in the fields of medical technologies and high-tech. Over her career, Marie has led major national and international development programs that have led to the creation of several start-ups in the fields of electronics, optics and microelectronics. She has been exclusively dedicated to EOS imaging since 2008.